Latest News about Financing
Recent news which mentions Financing
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
March 04, 2024
From Benzinga
Private Equity Goes Cold On IPOs: We Offer A Better Alternative, Says Canaccord Genuity Manager
March 01, 2024
From Benzinga
GH Research: This European Biotech Company Reports Full Year 2023 Financial Results And Business Updates
February 29, 2024
From Benzinga
Compass Pathways Shows Robust 2023 Year-End Results, Embraces Clinical Milestones For Psilocybin As Depression Treatment
February 29, 2024
Tickers
CMPS
From Benzinga
MindMed's 2023 Financial Results And Business Recap: Milestones Amid Rising Expenses
February 28, 2024
Tickers
MNMD
From Benzinga
A New Financing Option For Cannabis Companies Launches: Understanding The Importance Of Being At The Right Place
February 28, 2024
From Benzinga
Why Is Diabetes Focused vTv Therapeutics Stock Trading Higher Today?
February 28, 2024
From Benzinga
Commercial Real Estate Grapples With $1 Trillion Refinancing Tsunami In 2024, Over $200 Billion In Office Debt
February 28, 2024
From Benzinga
Viking Therapeutics' Weight Loss Study Data Outperformed Novo Nordisk, Eli Lilly Studies, Analysts Say
February 28, 2024
From Benzinga
FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disorder
February 28, 2024
From Benzinga
From Benzinga
Rio Tinto's Management Greenlights World's Largest Global Mining Project
February 22, 2024
From Benzinga
First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks
February 21, 2024
From Benzinga
Financial Relief For Cannabis As Green Check Adds Major Partners
February 21, 2024
Tickers
NEWS
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.